Medications
FDA: Zofran 32-mg dose pulled from market
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0
